Matthew P. Young
CIK: 0001601583
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
CTMX
CytomX Therapeutics, Inc.
Director
Discretionary Trading P&L
Holdings
About Young Matthew P.
Young Matthew P. (SEC CIK 0001601583) files insider reports with the SEC as Director of CytomX Therapeutics, Inc. (CTMX).
Signal8 holds 2 ownership filings by Young Matthew P., all Form 4s, filed between Jun 13, 2025 and Jun 22, 2026. Those filings report 2 transactions, from Jun 11, 2025 to Jun 17, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Young Matthew P.'s filings is in SOUTH SAN FRANCISCO, CA.
Recent filings by Young Matthew P.
Other insiders filing for CytomX Therapeutics, Inc. (CTMX)
- McCarthy Sean A., CEO
- Carvajal Alejandra, Chief Legal Officer
- Fuchs Charles S., Director
- Su Zhen, Director
- Mohindru Mani, Director
- Meyers James R, Director